GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (LSE:TCF) » Definitions » 3-Year Book Growth Rate

TheraCryf (LSE:TCF) 3-Year Book Growth Rate : -15.10% (As of Sep. 2023)


View and export this data going back to 2015. Start your Free Trial

What is TheraCryf 3-Year Book Growth Rate?

TheraCryf's Book Value per Share for the quarter that ended in Sep. 2023 was £0.01.

During the past 12 months, TheraCryf's average Book Value per Share Growth Rate was -46.20% per year. During the past 3 years, the average Book Value per Share Growth Rate was -15.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was -5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 11 years, the highest 3-Year average Book Value per Share Growth Rate of TheraCryf was 262.20% per year. The lowest was -39.50% per year. And the median was 1.60% per year.


Competitive Comparison of TheraCryf's 3-Year Book Growth Rate

For the Biotechnology subindustry, TheraCryf's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TheraCryf's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TheraCryf's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where TheraCryf's 3-Year Book Growth Rate falls into.



TheraCryf 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


TheraCryf  (LSE:TCF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


TheraCryf 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of TheraCryf's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


TheraCryf (LSE:TCF) Business Description

Traded in Other Exchanges
Address
Congleton Road, Suite 24G13- Block 24, Alderley Park, Nether Alderley, GBR, SK10 4TG
Evgen Pharma PLC is a UK-based clinical-stage drug development company. The company is focused on the development of sulforaphane-based compounds. Its core technology is Sulforadex, which synthesis and stabilizes the naturally occurring compound sulforaphane. Geographically, the company operates only in the United Kingdom. It is engaged in the treatment of breast cancer and Subarachnoid Haemorrhage.

TheraCryf (LSE:TCF) Headlines

From GuruFocus

New TCF Banking Center Opens on West Seven Mile in Detroit

By Business Wire Business Wire 02-26-2021

TCF Declares Quarterly Cash Dividends

By Business Wire Business Wire 01-27-2021